Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Drug Safety News

Home | Index > Health > Hot Topics > Drug Safety

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

Drug Development: Study data from Bristol-Myers Squibb Company provide new insights into drug development 23 Nov 2009 05:14 GMT
... States, "In the 5 years since the debacle, efforts have been made to enhance drug safety." "These include the introduction of legislation that expands the power of drug regulatory agencies, ...
People's Pharmacy: Herbal medicines instead of NSAIDs 23 Nov 2009 00:54 GMT
... meloxicam. Such medications can cause ringing in the ears (tinnitus) and even hearing loss (Drug Safety, March 1996). Dealing with arthritis, bone spurs, and back and knee inflammation can be ...
If your ears are ringing, perhaps you just have taken a painkiller 22 Nov 2009 06:58 GMT
... meloxicam. Such medications can cause ringing in the ears (tinnitus) and even hearing loss (Drug Safety, March 1996). Dealing with arthritis, bone spurs and back and knee inflammation can be ...
The People's Pharmacy | People's Pharmacy: Pain relief for people who can't use NSAID drugs 22 Nov 2009 08:47 GMT
... meloxicam. Such medications can cause ringing in the ears (tinnitus) and even hearing loss (Drug Safety, March 1996). Dealing with arthritis, bone spurs and back and knee inflammation can be ...
People's Pharmacy: Pain relief for people who can't use NSAID drugs 22 Nov 2009 19:01 GMT
... meloxicam. Such medications can cause ringing in the ears (tinnitus) and even hearing loss (Drug Safety, March 1996). Dealing with arthritis, bone spurs and back and knee inflammation can be ...

CTSA institutions receive NIH grants to study drug safety and efficacy in children 18 Nov 2009 07:16 GMT
... Studying drugs in pediatric populations is challenging because drugs often affect children differently than they do ...
BRIEF-US FDA panel-Data adequate on Pfizer lung drug safety concerns 19 Nov 2009 20:36 GMT
... WASHINGTON, Nov 19 (Reuters) - A U.S. Food and Drug Administration advisory panel on Thursday: * ...
CORRECTED - UPDATE 3-US FDA staff question Pfizer lung drug data 17 Nov 2009 23:10 GMT
... stroke and death from heart disease. In the documents released on Tuesday, the FDA's drug safety unit said available data suggesting an increased risk was "not compelling." FDA staff noted, however, ...
US FDA staff question Pfizer lung drug data 18 Nov 2009 02:30 GMT
... stroke and death from heart disease. In the documents released on Tuesday, the FDA's drug safety unit said available data suggesting an increased risk was "not compelling." FDA staff noted, however, ...
US FDA staff question Pfizer's lung drug data 17 Nov 2009 23:15 GMT
... stroke and death from heart disease. In the documents released on Tuesday, the FDA's drug safety unit said available data suggesting an increased risk was "not compelling." FDA staff noted, however, ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 19 Nov 2009 16:20 GMT
... Recent multinational initiatives under the Council for International Organizations of Medical Sciences (CIOMS) on Drug Safety Update Reports (DSURs) in premarketing clinical trial safety • New approaches to risk management, risk ...
UPDATE 2-US FDA staff question Pfizer's lung drug data 17 Nov 2009 20:30 GMT
... stroke and death from heart disease. In the documents released on Tuesday, the FDA's drug safety unit said available data suggesting an increased risk was "not compelling." FDA staff noted, however, ...
UPDATE 3-US FDA staff question Pfizer lung drug data 17 Nov 2009 22:10 GMT
... stroke and death from heart disease. In the documents released on Tuesday, the FDA's drug safety unit said available data suggesting an increased risk was "not compelling." FDA staff noted, however, ...
CORRECTED-UPDATE 3-US FDA staff question Pfizer lung drug data 17 Nov 2009 23:34 GMT
... stroke and death from heart disease. In the documents released on Tuesday, the FDA's drug safety unit said available data suggesting an increased risk was 'not compelling.' FDA staff noted, however, ...
Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 18 Nov 2009 14:30 GMT
... innovative technology from RBM, along with Covance's other biomarker capabilities, are critical tools for drug safety and efficacy testing that can help our clients make better decisions earlier in drug development ...
RBM/Covance Alliance to Strengthen Integrated Biomarker Capabilities Spanning Drug Development Continuum - 18 Nov 2009 17:53 GMT
... innovative technology from RBM, along with Covance’s other biomarker capabilities, are critical tools for drug safety and efficacy testing that can help our clients make better decisions earlier in drug development ...
Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. (PRN) 18 Nov 2009 14:34 GMT
... "This innovative technology from RBM, along with other biomarker capabilities, are critical tools for drug safety and efficacy testing that can help our clients make better decisions earlier in drug development ...
U.S. FDA advisory meetings through March 25 17 Nov 2009 00:36 GMT
... transplanted kidney. JOINT MEETING OF THE CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE AND THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE DATE: Dec 8, 0800/1300 LOCATION: Hilton, 620 Perry Parkway, Gaithersburg, ...
UPDATE 2-US FDA sees varying risk from MRI agents 17 Nov 2009 23:34 GMT
... kidney and liver conditions were at risk for for NSF. Staff in the FDA's drug safety unit said the magnitude of the risk 'does not compel removal of specific (imaging agents) ...
Covance and Rules-Based Medicine enter into biomarker alliance and services agreement 19 Nov 2009 06:14 GMT
... and President of Covance Central Laboratory Services. "These innovative technologies are critical tools for drug safety and efficacy testing, which help enable our clients to make better decisions and accelerate their ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 18 Nov 2009 14:30 GMT
... and President of Covance Central Laboratory Services. "These innovative technologies are critical tools for drug safety and efficacy testing, which help enable our clients to make better decisions and accelerate their ...
Clinical Data, Inc. Establishes Scientific Advisory Board for Cardiovascular Genetics (BIZ) 17 Nov 2009 12:50 GMT
... well as genetic and pharmacogenomic tests that detect serious diseases and help to predict drug safety and efficacy. By using innovative technologies and working with some of the world's most prestigious ...
Clinical Data, Inc. Establishes Scientific Advisory Board for Cardiovascular Genetics 17 Nov 2009 12:50 GMT
... well as genetic and pharmacogenomic tests that detect serious diseases and help to predict drug safety and efficacy. By using innovative technologies and working with some of the world's most prestigious ...
Clinical Data, Inc. Establishes Scientific Advisory Board for Cardiovascular Genetics 17 Nov 2009 12:54 GMT
... well as genetic and pharmacogenomic tests that detect serious diseases and help to predict drug safety and efficacy. By using innovative technologies and working with some of the world's most prestigious ...
Clinical Data, Inc. Establishes Scientific Advisory Board for Cardiovascular Genetics (BIZ) 17 Nov 2009 13:14 GMT
... well as genetic and pharmacogenomic tests that detect serious diseases and help to predict drug safety and efficacy. By using innovative technologies and working with some of the world's most prestigious ...